Biotech · Private company
Peerbridge Health, Inc
Track this companyFree. Adds Peerbridge Health, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- 15-minutes of sitting during COR ECG AcquistionVentricular Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- COR Wearable ECG MonitoringCardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- Cor360 Clinician-Facing Decision-Aid ReportingCardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL ACardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL BCardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL CCardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL DCardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL ECardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
- SUBPROTOCOL FCardiopulmonary FailureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care PathwaysENROLLING_BY_INVITATION · started Aug 20, 2026ClinicalTrials.gov NCT07775976 · fetched Nov 12, 2026
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable MonitorRECRUITING · started Nov 21, 2024ClinicalTrials.gov NCT06699056 · fetched Nov 12, 2026
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableENROLLING_BY_INVITATION · started Nov 16, 2024ClinicalTrials.gov NCT06763549 · fetched Nov 12, 2026